Is Puma Biotechnology Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: PBYI) stock is to Buy PBYI stock.
Out of 1 analyst, 0 (0%) are recommending PBYI as a Strong Buy, 1 (100%) are recommending PBYI as a Buy, 0 (0%) are recommending PBYI as a Hold, 0 (0%) are recommending PBYI as a Sell, and 0 (0%) are recommending PBYI as a Strong Sell.
What is PBYI's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: PBYI) forecast ROE is N/A, which is considered weak.
What is PBYI's Price Target?
According to 1 Wall Street analyst that have issued a 1 year PBYI price target, the average PBYI price target is $8.00, with the highest PBYI stock price forecast at $8.00 and the lowest PBYI stock price forecast at $8.00.
The Wall Street analyst predicted that Puma Biotechnology's share price could reach $8.00 by Jun 5, 2024. The average Puma Biotechnology stock price prediction forecasts a potential upside of 136.69% from the current PBYI share price of $3.38.
What is PBYI's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: PBYI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.09%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.